• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Tecnis Toric 1-Piece IOL gets FDA nod

Article

The FDA approved Abbot’s Tecnis Toric 1-Piece IOL for the treatment of cataract with pre-existing corneal astigmatism.

Abbott Park, IL-Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Toric 1-Piece intraocular lens (IOL) for the treatment of cataract with pre-existing corneal astigmatism. Abbot will launch the product in the U.S.

According to the company, the IOL remains very stable once inserted into the eye and meets the new standard for toric IOL rotational stability as approved by the American National Standards Institute (ANSI). Tecnis Toric 1-Piece also minimizes spherical aberration for better distance vision. 

Related Videos
Thomas V. Johnson, MD, PhD, of Wilmer Eye Institute discusses his EyeCon 2023 presentation
Mila Ioussifova, OD, FAAO
Jacob R. Lang, OD, FAAO
© 2023 MJH Life Sciences

All rights reserved.